It was reported that this implantable cardioverter defibrillator (icd) delivered inappropriate anti-tachycardia pacing (atp) and several shocks for a rhythm that was felt to be sinus tachycardia.When the rhythm was initially detected, v greater than a was true.The rhythm then accelerated and v greater than a became false, however, atp and shock therapy was delivered and resulted in exhaustion of tachycardia therapy.The local field representative contacted boston scientific technical services (ts) and inquired if detection enhancements are available during the redetection phase.Ts discussed that detection enhancements are only applied during initial detection.No adverse patient effects were reported.This product remains implanted and in service.
|